Digoxin may reduce heart failure hospitalizations by 25%

New research suggests that low doses of digoxin, an inexpensive medication costing less than ten cents per day, may significantly reduce hospitalizations for patients with heart failure.

Three studies led by cardiologists Dirk Jan van Veldhuisen, Kevin Damman, and Peter van der Meer from the University Medical Center Groningen (UMCG) provide evidence for the drug's efficacy. The findings, published in journals including Nature Medicine and the Journal of the American Medical Association (JAMA), suggest that digoxin could serve as a beneficial fifth component alongside the current standard of care, often referred to as the ‘Fantastic Four’ medications.

One primary clinical study, DECISION, involved 1,001 patients across 43 centers in the Netherlands. While some individual metrics showed varying levels of statistical significance, the combined data from multiple large-scale randomized trials indicates that the medication can help prevent the worsening of heart failure and reduce the frequency of hospital visits.